Compare
Viant Technology Inc. vs Yalla Group Ltd vs Health Catalyst, Inc. vs Healthstream Inc
| Latest fiscal year | Viant Technology Inc. DSP | Yalla Group Ltd YALA | Health Catalyst, Inc. HCAT | Healthstream Inc HSTM |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $344.20M | $341.94M | $311.14M | $304.06M |
| Revenue growth (YoY) | +19.0% | +0.7% | +1.5% | +4.3% |
| Gross margin | 45.8% (computed) | 67.3% (computed) | n/a | n/a |
| Operating margin | 3.5% | 35.7% | -51.7% | 6.7% |
| Net margin | 7.0% | 43.3% | -57.2% | 6.0% |
| Net income | $24.10M | $148.14M | -$177.97M | $18.34M |
| EPS (Diluted) | $0.36 | $0.83 | -$2.55 | $0.61 |
| Operating cash flow | $52.61M | $137.54M | $731.0K | $63.32M |
| Free cash flow | $51.68M | $135.56M | -$237.0K | $59.63M |
| Cash & equivalents | n/a | $526.97M | $50.81M | $36.16M |
| Total assets | $474.66M | $896.22M | $502.64M | $520.37M |
| Total liabilities | $185.86M | $94.17M | $256.86M | n/a |
| Shareholders' equity | $288.80M | $810.28M | $245.78M | $354.02M |
| Return on year-end equity | 8.3% | 18.3% | -72.4% | 5.2% |
| Shares outstanding | n/a | n/a | 72.03M | 29.58M |
Revenue, most recent five fiscal years
| Fiscal year | Viant Technology Inc. | Yalla Group Ltd | Health Catalyst, Inc. | Healthstream Inc |
|---|---|---|---|---|
| Latest | $344.20M Ended 2025-12-31 | $341.94M Ended 2025-12-31 | $311.14M Ended 2025-12-31 | $304.06M Ended 2025-12-31 |
| 1 year earlier | $289.24M Ended 2024-12-31 | $339.68M Ended 2024-12-31 | $306.58M Ended 2024-12-31 | $291.65M Ended 2024-12-31 |
| 2 years earlier | $222.93M Ended 2023-12-31 | $318.88M Ended 2023-12-31 | $295.94M Ended 2023-12-31 | $279.06M Ended 2023-12-31 |
| 3 years earlier | $197.17M Ended 2022-12-31 | $303.60M Ended 2022-12-31 | $276.24M Ended 2022-12-31 | $266.83M Ended 2022-12-31 |
| 4 years earlier | $224.13M Ended 2021-12-31 | $273.13M Ended 2021-12-31 | $241.93M Ended 2021-12-31 | $256.71M Ended 2021-12-31 |